dromlakhani/md2skill/noveltreat-storage-handling

Noveltreat Pre-filled Pen — Storage and Handling

Applies to Noveltreat® Semaglutide Injection Pen strengths 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg (single-use pre-filled pen).

Before First Use

• Refrigerate at 2–8 °C in the original carton.
• Do not freeze.
• Do not use if the pen is expired, damaged, or the solution is not clear.
• Keep the cap on until ready to inject.

After First Use

• Single-use pen — do not reuse.
• The needle is hidden and the pen auto-locks after use (built-in safety).

Out-of-Fridge (pre-use) Stability

• Once the cap has been removed (or the pen is taken from the fridge for use), the pen may be kept unrefrigerated for up to 28 days at a temperature not exceeding 30 °C.

In-Use Stability

• Discard the pen if it has been out of the refrigerator for > 28 days.

Environmental Restrictions

Disposal

• Dispose of used pens per the doctor's or pharmacist's instructions.
• Use a puncture-resistant container (heavy-duty plastic or equivalent, with a tight-fitting, puncture-resistant lid; upright, stable, leak-resistant, and clearly labelled as hazardous biomedical waste).
• Do not recycle the pen.
• Do not reuse the pen.
• The pen cap and empty carton may be disposed of in household waste.
• Follow local biomedical-waste regulations.

Patient Counseling Points

• Store the unopened pen in the fridge; take it out when you are ready to inject.
• You do not have to wait for the pen to warm to room temperature — but you can, if cold injection is uncomfortable.
• Mark the first-use date on the carton so you know when 28 days are up.
• If the pen has been frozen — even if it now looks normal — throw it away.
• Keep the pen and used sharps container out of reach of children.

Quick Decision Rules

• Pen in the fridge, unopened, not expired → use.
• Pen out of fridge ≤ 28 days, cap kept on, ≤ 30 °C → use.
• Pen out of fridge > 28 days → discard.
• Pen frozen at any point → discard.
• Pen dropped or cloudy / discoloured → discard.

Cross-References

• Prescribing, dose escalation, missed dose → noveltreat-prescribing-guide
• Matching a patient to evidence → noveltreat-patient-profile-matcher

Reference

Sun Pharmaceutical Industries Ltd. Product Monograph — Diabetes and Obesity (Sematrinity® and Noveltreat®), 2026 — Storage and Handling section (Data on file).